株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

癌性疼痛:世界の治験動向

Cancer Pain Global Clinical Trials Review, H1, 2017

発行 GlobalData 商品コード 237452
出版日 ページ情報 英文 268 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.37円で換算しております。
Back to Top
癌性疼痛:世界の治験動向 Cancer Pain Global Clinical Trials Review, H1, 2017
出版日: 2017年05月31日 ページ情報: 英文 268 Pages
概要

当レポートでは、癌性疼痛の治験 (臨床試験) に関する最新動向について分析しており、地域別の治験件数、治験の段階別進行状況、被験者採用の状況、有望なスポンサー、各企業や研究機関における研究の進行状況、有望な薬剤の比較といった情報をまとめています。

イントロダクション

  • 癌性疼痛
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要5カ国における治験件数
    • 中南米の主要5カ国における治験件数

G7諸国での治験件数:中枢神経系疾患治療薬の治験における癌性疼痛の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:中枢神経系疾患治療薬の治験における癌性疼痛の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

癌性疼痛治療薬の治験に携わっている主要企業

有望な薬剤

最新の治験ニュース

治験のプロファイル

  • 主要企業の治験の概要
    • Johnson & Johnson
    • Janssen Global Services, LLC
    • Mundipharma International Ltd
    • キリンホールディングス
    • GW Pharmaceuticals Plc
    • Grunenthal GmbH
    • 武田薬品工業
    • Pfizer Inc.
    • 大塚ホールディングス
    • 協和発酵キリン
  • 代表的な研究機関・病院の治験の概要
    • Alberta Health Services
    • Erasmus MC
    • Mario Negri Institute for Pharmacological Research
    • Mayo Clinic
    • Norwegian University of Science and Technology
    • Assistance Publique - Hopitaux de Paris
    • Chinese University of Hong Kong
    • Chonbuk National University Hospital
    • Gloucestershire Hospitals NHS Trust
    • Indiana University

5つの代表的な治験のプロファイル

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC4238CTIDB

GlobalData's clinical trial report, "Cancer Pain Global Clinical Trials Review, H1, 2017" provides an overview of Cancer Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Cancer Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Five Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Cancer Pain to Central Nervous System Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Cancer Pain to Central Nervous System Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials in E7 Countries by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 24
  • Subjects Recruited Over a Period of Time 25
  • Clinical Trials by Sponsor Type 26
  • Prominent Sponsors 27
  • Top Companies Participating in Cancer Pain Therapeutics Clinical Trials 28
  • Prominent Drugs 29
  • Latest Clinical Trials News on Cancer Pain 30
  • Apr 19, 2017: Kancera has applied for a clinical trial for KAND567 30
  • Clinical Trial Profile Snapshots 31

Appendix 266

  • Abbreviations 266
  • Definitions 266
  • Research Methodology 267
  • Secondary Research 267
  • About GlobalData 268
  • Contact Us 268
  • Source 268

List of Tables

List of Tables

  • Cancer Pain Therapeutics, Global, Clinical Trials by Region, 2017* 7
  • Cancer Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Cancer Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Cancer Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
  • Cancer Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
  • Cancer Pain Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
  • Cancer Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 13
  • Cancer Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 14
  • Proportion of Cancer Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 15
  • Cancer Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
  • Cancer Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Cancer Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 18
  • Cancer Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
  • Cancer Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
  • Cancer Pain Therapeutics, Global, Clinical Trials by Phase, 2017* 21
  • Cancer Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
  • Cancer Pain Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
  • Cancer Pain Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
  • Cancer Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
  • Cancer Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26
  • Cancer Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
  • Cancer Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
  • Cancer Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29

List of Figures

List of Figures

  • Cancer Pain Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
  • Cancer Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Cancer Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Cancer Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
  • Cancer Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
  • Cancer Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
  • Cancer Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 13
  • Cancer Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 14
  • Proportion of Cancer Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 15
  • Cancer Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
  • Cancer Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Cancer Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 18
  • Cancer Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
  • Cancer Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
  • Cancer Pain Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
  • Cancer Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
  • Cancer Pain Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
  • Cancer Pain Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
  • Cancer Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
  • Cancer Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26
  • Cancer Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
  • Cancer Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
  • Cancer Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29
  • GlobalData Methodology 267
Back to Top